Trial Profile
A clinical study on safety and efficacy of combined intraarterial cisplatin and 5-fluorouracil with systemic pegylated interferon alfa-2b for advanced hepatocellular carcinoma
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 20 Nov 2012
Price :
$35
*
At a glance
- Drugs Peginterferon alfa-2b (Primary) ; Cisplatin; Fluorouracil
- Indications Liver cancer
- Focus Therapeutic Use
- 30 Oct 2012 New trial record
- 13 Oct 2012 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan